DCT
1:25-cv-02135
Shoei Chemical Inc v. Nanoco Tech Ltd
Key Events
Complaint
Table of Contents
complaint Intelligence
I. Executive Summary and Procedural Information
- Parties & Counsel:
- Plaintiff: Shoei Chemical Inc. (Japan) and Shoei Electronic Materials, Inc. (Delaware)
- Defendant: Nanoco Technologies Ltd. (United Kingdom)
- Plaintiff's Counsel: Latham & Watkins LLP
- Case Identification: 1:25-cv-02135, E.D. Va., 11/21/2025
- Venue Allegations: Plaintiffs assert venue is proper because Defendant, a non-resident patentee, is subject to personal jurisdiction in the court pursuant to 35 U.S.C. § 293.
- Core Dispute: Plaintiffs seek a declaratory judgment that their quantum dot products and manufacturing methods do not infringe four of Defendant's patents, following Defendant's prior infringement suit against Plaintiffs' customer, LG Electronics.
- Technical Context: The dispute centers on the manufacturing methods and composition of quantum dots (QDs), which are semiconductor nanocrystals used in advanced electronic displays due to their size-tunable light-emitting properties.
- Key Procedural History: This action follows a prior lawsuit where Defendant Nanoco accused Plaintiffs' customer, LG Electronics (LGE), of infringing the same four patents by incorporating Plaintiffs' QDs into its products. That case was settled and dismissed. During the LGE case, Nanoco served infringement contentions that identified Plaintiffs' QDs and methods as the basis for the allegations. All asserted claims in the four patents-in-suit recently survived Inter Partes Review (IPR) proceedings, a factor that may inform the court's view of their validity.
Case Timeline
| Date | Event |
|---|---|
| 2004-04-30 | Earliest Priority Date ('828, '423, '365 Patents) |
| 2005-08-12 | Priority Date ('557 Patent) |
| 2009-09-15 | U.S. Patent 7,588,828 Issues |
| 2010-09-28 | U.S. Patent 7,803,423 Issues |
| 2011-01-11 | U.S. Patent 7,867,557 Issues |
| 2013-09-03 | U.S. Patent 8,524,365 Issues |
| 2020-11-09 | IPRs filed against all four Patents-in-Suit |
| 2023-03-28 | IPR Certificate Issues for '557 Patent |
| 2023-03-29 | IPR Certificate Issues for '423 Patent |
| 2023-03-30 | IPR Certificate Issues for '828 Patent |
| 2023-04-11 | IPR Certificate Issues for '365 Patent |
| 2025-04-24 | Nanoco files suit against LGE in E.D. Tex. |
| 2025-08-29 | LGE moves to transfer the LGE case |
| 2025-09-16 | Nanoco serves Preliminary Infringement Contentions in LGE case |
| 2025-10-02 | Nanoco serves discovery on Shoei's subsidiary in LGE case |
| 2025-11-21 | Nanoco and LGE settle; LGE case is dismissed |
| 2025-11-21 | Shoei files this Declaratory Judgment Complaint |
II. Technology and Patent(s)-in-Suit Analysis
U.S. Patent No. 7,588,828 - "PREPARATION OF NANOPARTICLE MATERIALS"
- Patent Identification: U.S. Patent No. 7,588,828, "PREPARATION OF NANOPARTICLE MATERIALS," issued September 15, 2009.
The Invention Explained
- Problem Addressed: The patent describes the difficulty in producing uniform semiconductor nanoparticles (quantum dots) with high quantum efficiency, as conventional methods can lead to surface defects and are challenging to scale up for mass production '828 Patent, col. 1:15-28 '828 Patent, col. 4:40-44
- The Patented Solution: The invention proposes using a "molecular cluster compound" as a pre-defined seed or template upon which nanoparticles can grow '828 Patent, abstract By providing a well-defined nucleation site from the start, the process avoids a spontaneous, high-temperature nucleation event, allowing for the creation of a more uniform, or monodisperse, population of nanoparticles '828 Patent, col. 4:21-38 The process is depicted in Figure 3, which shows a molecular seed (310) initiating the growth of a nanoparticle (350) from precursor materials '828 Patent, Fig. 3
- Technical Importance: This seeded-growth approach offered a pathway to greater control over the size distribution and quality of quantum dots, which is crucial for their performance in optical applications, while also being more suitable for large-scale manufacturing '828 Patent, col. 4:38-44
Key Claims at a Glance
- The complaint identifies independent claims 1 (a product claim) and 14 (a method claim) as having been asserted by Nanoco Compl. ¶¶27-28
- Independent Claim 1 recites a nanoparticle comprising:
- a molecular cluster compound incorporating ions from groups 12 and 16 of the periodic table, and
- a core semiconductor material provided on said molecular cluster compound,
- wherein the core semiconductor material incorporates ions from groups 13 and 15 of the periodic table.
- Independent Claim 14 recites a method of producing nanoparticles comprising the steps of:
- providing a nanoparticle precursor composition comprising group 13 ions and group 15 ions; and
- effecting conversion of the precursor into nanoparticles,
- wherein the conversion is effected in the presence of a molecular cluster compound incorporating group 12 and group 16 ions under conditions permitting nanoparticle seeding and growth.
- The complaint notes that dependent claims 3-5 and 8-14 were also asserted in the prior LGE case Compl. ¶25
U.S. Patent No. 7,803,423 - "PREPARATION OF NANOPARTICLE MATERIALS"
- Patent Identification: U.S. Patent No. 7,803,423, "PREPARATION OF NANOPARTICLE MATERIALS," issued September 28, 2010.
The Invention Explained
- Problem Addressed: Similar to related patents, this invention addresses the need for methods that produce highly uniform (monodisperse) nanoparticles with consistent properties, a key challenge in colloidal synthesis '423 Patent, col. 1:14-25 '423 Patent, col. 4:8-14
- The Patented Solution: The patent claims a method of producing nanoparticles by converting a precursor composition (containing first and second ions) in the presence of a "molecular cluster compound" that acts as a seed for growth '423 Patent, claim 1 A key aspect of the invention is that this molecular cluster seed is chemically "different from the first precursor species and the second precursor species," creating a distinction between the seeding template and the materials used for subsequent growth '423 Patent, abstract '423 Patent, col. 4:59-65
- Technical Importance: Employing a seeding agent that is chemically distinct from the growth precursors provides a versatile method for controlled nucleation, expanding the potential materials and structures that can be synthesized with high precision.
Key Claims at a Glance
- The complaint identifies independent claims 1 and 25 as having been asserted by Nanoco Compl. ¶¶37-38
- Independent Claim 1 recites a method of producing nanoparticles comprising:
- effecting conversion of a nanoparticle precursor composition to a material of the nanoparticles,
- said precursor composition comprising a first precursor species... and a separate second precursor species...,
- wherein said conversion is effected in the presence of a molecular cluster compound different from the first and second precursor species under conditions permitting seeding and growth.
- Independent Claim 25 adds a specific thermal processing step to the method of Claim 1, reciting:
- ...wherein the molecular cluster compound and precursor composition are dissolved at a first temperature...
- ...and the temperature is then increased to a second temperature which is sufficient to initiate seeding and growth...
- The complaint notes that numerous dependent claims were also asserted in the prior LGE case Compl. ¶35
U.S. Patent No. 7,867,557 - "NANOPARTICLES"
- Patent Identification: U.S. Patent No. 7,867,557, "NANOPARTICLES," issued January 11, 2011.
- Technology Synopsis: This patent discloses a method for producing a multi-layered nanoparticle with a core, a first layer (shell), and a second layer '557 Patent, abstract The method involves first forming the core through a seeded growth process initiated by a "molecular cluster compound" and then subsequently depositing the distinct shell layers '557 Patent, claim 1 This core/multi-shell architecture is designed to enhance the optical properties and stability of the quantum dots.
- Asserted Claims: Independent claim 1 Compl. ¶47
- Accused Features: Nanoco's infringement allegations, as described by Shoei, target the "manufacture, sale, offer for sale, use, and/or importation" of Shoei's QD products Compl. ¶44 The non-infringement argument is premised on the assertion that Shoei's methods do not utilize a "molecular cluster compound" as required by the claim Compl. ¶48
U.S. Patent No. 8,524,365 - "PREPARATION OF NANOPARTICLE MATERIALS"
- Patent Identification: U.S. Patent No. 8,524,365, "PREPARATION OF NANOPARTICLE MATERIALS," issued September 3, 2013.
- Technology Synopsis: This patent claims a nanoparticle composition, rather than a method. The composition comprises a molecular cluster compound and a "core semiconductor material disposed on the molecular cluster compound," where the core material includes elements not present in the seed cluster '365 Patent, abstract '365 Patent, claim 1 It protects the resulting structure of a nanoparticle grown from a chemically distinct seed.
- Asserted Claims: Independent claim 1 Compl. ¶56
- Accused Features: The complaint states Nanoco alleges Shoei's QD products infringe the patent Compl. ¶53 Shoei's defense is that its products do not contain the claimed "molecular cluster compound" as a structural component Compl. ¶57
III. The Accused Instrumentality
- Product Identification: The products and methods at issue are identified as Shoei's quantum dots ("QDs"), referred to as the "Accused Products," and Shoei's methods for manufacturing them, referred to as the "Accused Methods" Compl. ¶16
- Functionality and Market Context: The complaint alleges that Shoei is a "world-leading supplier" of QDs for the electronics market Compl. ¶5 These QDs were incorporated into various consumer electronics, such as TVs, monitors, and mobile phones, sold by Shoei's customer LGE Compl. ¶15 Shoei also sells and offers for sale in the United States QDs for use in products other than LGE's, including as samples for research and development and for use in other commercial products Compl. ¶21
No probative visual evidence provided in complaint.
IV. Analysis of Infringement Allegations
The complaint, seeking a declaratory judgment of non-infringement, asserts that Shoei's products and methods do not practice a key element common to all asserted patents: the use of a "molecular cluster compound." The following tables summarize this central dispute for the two lead patents, based on the allegations described in the complaint.
'828 Patent Infringement Allegations
| Claim Element (from Independent Claim 1) | Alleged Infringing Functionality | Complaint Citation | Patent Citation |
|---|---|---|---|
| (i) a molecular cluster compound incorporating ions from groups 12 and 16 of the periodic table | Shoei's manufacturing methods for its QDs, which Nanoco alleges utilize or form such a compound to seed nanoparticle growth. | ¶29 | col. 4:26-38 |
| (ii) a core semiconductor material provided on said molecular cluster compound, wherein the core semiconductor material incorporates ions from groups 13 and 15 of the periodic table | The core material of Shoei's QDs, which Nanoco alleges is grown upon the aforementioned molecular cluster compound. | ¶29 | col. 4:45-51 |
'423 Patent Infringement Allegations
| Claim Element (from Independent Claim 1) | Alleged Infringing Functionality | Complaint Citation | Patent Citation |
|---|---|---|---|
| effecting conversion of a nanoparticle precursor composition to a material of the nanoparticles... | The growth phase in Shoei's QD manufacturing process where precursor chemicals are converted into nanoparticle material. | ¶39 | col. 5:1-12 |
| wherein said conversion is effected in the presence of a molecular cluster compound different from the first precursor species and the second precursor species... | The nucleation or seeding phase of Shoei's QD manufacturing process. Shoei denies its process is effected in the presence of the claimed "molecular cluster compound." | ¶39 | col. 4:1-13 |
- Identified Points of Contention:
- Definitional Question: The dispute for all four patents appears to center on the claim term "molecular cluster compound." The core question for the court will be whether the starting materials or any in-situ-formed intermediates in Shoei's manufacturing process fall within the patents' definition of this term.
- Technical Question: A factual dispute exists over the actual mechanism of nanoparticle nucleation in Shoei's process. Nanoco's infringement allegations, as presented in the complaint, suggest Shoei's process uses a seeding mechanism equivalent to the claimed invention, while Shoei's denial implies its process relies on a different, non-infringing nucleation method Compl. ¶29 Compl. ¶39 Compl. ¶48 Compl. ¶57
V. Key Claim Terms for Construction
The construction of the following term appears to be dispositive of the non-infringement dispute.
- The Term: "molecular cluster compound"
- Context and Importance: This term appears in the independent claims of all four patents-in-suit. Shoei's declaratory judgment complaint is founded entirely on the argument that its accused products and methods do not contain or use such a compound Compl. ¶29 Compl. ¶39 Compl. ¶48 Compl. ¶57 Consequently, the court's interpretation of this term will likely determine the outcome of the infringement analysis for the entire case.
- Intrinsic Evidence for Interpretation:
- Evidence for a Broader Interpretation: The specification suggests the compound can be "prefabricated or produced in situ" '828 Patent, col. 4:52-54 Nanoco may argue this language supports a construction that covers not only pre-synthesized clusters but also transient molecular aggregates that form within the reaction vessel and serve as nucleation sites.
- Evidence for a Narrower Interpretation: The specification provides a specific definition: "clusters of three or more metal atoms and their associated ligands of sufficiently well-defined chemical structure such that all molecules of the cluster compound possess approximately the same relative molecular formula" '828 Patent, col. 4:29-35 Shoei may argue that the phrases "well-defined chemical structure" and "identical to one another in the same way that one H₂O molecule is identical to another" '828 Patent, col. 4:35-38 require a discrete, stable, and uniform chemical species, thereby excluding less-defined agglomerations that might occur in a conventional (non-seeded) nucleation process.
VI. Other Allegations
- Indirect Infringement: The complaint seeks a declaration of non-infringement for direct, indirect, and other forms of infringement Compl. ¶4 It also specifically requests a declaration that Shoei's customers do not infringe by using the accused products Compl. ¶32 The factual predicate for a potential indirect infringement claim by Nanoco is established by Shoei's alleged pre-suit knowledge of the patents and Nanoco's specific infringement allegations, gained during the prior LGE litigation Compl. ¶¶14-20
- Willful Infringement: While willfulness is not a cause of action in this declaratory judgment complaint, the facts alleged by Shoei to establish an "actual controversy" would simultaneously serve as the basis for a willfulness claim by Nanoco if infringement were ever found. The complaint details Nanoco's prior suit against Shoei's customer, service of infringement contentions, and discovery requests directed at Shoei's technology, all of which establish pre-suit knowledge of the alleged infringement Compl. ¶¶14-20
VII. Analyst's Conclusion: Key Questions for the Case
This declaratory judgment action appears poised to turn on two central questions that intertwine claim construction with technical evidence.
- A core issue will be one of definitional scope: How will the court construe the term "molecular cluster compound"? Will the definition be limited to discrete, stable, and structurally uniform chemical entities, as Shoei's position suggests, or will it be broad enough to encompass transient, in-situ formed nucleation sites that Nanoco may argue are present in Shoei's process?
- The dispositive evidentiary question will be one of process chemistry: Irrespective of the exact claim construction, what does Shoei's proprietary manufacturing process actually entail at the molecular level? The case will likely depend on expert testimony and discovery into Shoei's confidential methods to determine whether a compound meeting the court's definition of a "molecular cluster compound" is either used as an input or is necessarily formed as an intermediate.
Analysis metadata
Loading Complaint
Suggested improvements